Finimize - 😳 The biggest IPOs peaked too soon

Hi Reader, here's what you need to know for November 30th in 3:08 minutes.

🚨 There’s just two – count ’em, two – days to go till the Finimize x Ledger Crypto Summit. And if the possibility of discovering the next big thing in blockchain weren’t incentive enough, try this on for size: sign up for free today, and you’ll be entered into a draw to win a Ledger Nano, a year’s Finimize Premium subscription, and a bunch of Finimize swag. Get your free ticket here

Today's big stories

Russian gas producer Gazprom reported better-than-expected results
There are three groups of stocks that could do especially well from now till April – Read Now
Half of the companies involved in the year’s biggest IPOs are now trading below their listing prices

Hot Property

What’s Going On Here?

Gazprom reported better-than-expected results on Monday, as Europe lined up all day and all night to get its hands on the natural gas producer’s exclusive product.

What Does This Mean?

Russia’s Gazprom was already basking in rising natural gas prices last quarter, as Europe – the company’s biggest export market – continued to wrestle with the ongoing shortage. But there’s more to the story here: the Russian government also effectively limited how much gas Gazprom could sell to Europe, in hopes the company would replenish the country’s own stockpiles. Europe and Asia, then, were left to battle it out for an increasingly scarce supply, which pushed prices even higher. And that helped drive Gazprom’s revenue up by a better-than-expected 70% last quarter compared to the same time last year.

Why Should I Care?

The bigger picture: Gazprom has lots more in the pipeline.
Gazprom’s expecting even better things this quarter, with demand for gas used to heat homes only set to rise as winter rolls in. The company has a good feeling about the underwater pipeline it’s been trying to build too: Europe is concerned about its historically low stockpiles of natural gas, which means it might be more likely to give the setup – which would double the undersea amount Gazprom can deliver into the region – the green light.

Zooming out: The emerging market frontrunner?
Russia’s loving this energy boom: the country’s economy – which is closely tied to oil and natural gas – is on track to grow 4.7% this year compared to last, in what would be the biggest jump in 13 years. What’s more, forecasts for Russian companies’ profits in the next 12 months are 15% higher than they were in July, according to Bloomberg. That’s more than the companies in other emerging markets like Asia and Latin America, and could suggest its stock market is a better play than theirs too…

You might also like: How to profit from this natural gas boom.

Copy to share story: https://www.finimize.com/wp/news/one-of-a-kind/

🙋 Ask a question

Analyst Take

‘Tis The Season For Strong Stock Market Returns

Carl Hazeley, Analyst

What’s Going On Here?

There’s an old investing adage that goes, “sell in May and go away, and come back on St Ledger’s Day”.

And that principle has proved to be pretty accurate: US stocks do tend to perform better between November and April.

Since 1926, the S&P 500 has risen an annualized 7.2% between May and October, compared to 13.6% between November and April.

And there are actually three groups of US stocks that do even better than that.

So that’s today’s Insight: why US stocks tend to do so well over the festive period, and the three groups of stocks that could outperform between now and May.

Read or listen to the Insight here

Your bank balance needs a health boost

It’s been an interesting time for the healthcare industry, that’s for sure.

The sector’s stocks have been growing fast, and that means you could profit by investing in it soon. And boy, have we got an opportunity for you.

NowRx is a tech-enabled pharmacy that uses its proprietary software and robotics to fulfill free same-day deliveries.

It’s really taking off: NowRx has delivered over 365,000 prescriptions to more than 35,000 customers, and its stock is up 1,650% since it became available in 2016.

Its revenue is growing fast too: it climbed 90% from 2019 to 2020, and it’s on track to reach $22 million in 2021 alone.

NowRx has already raised $9 million from 2,700 investors, so you’ll need to be quick if you want to invest: find out more here.

Invest Today